Nutritional status of women with non-metastatic breast cancer receiving outpatient chemotherapy

被引:0
作者
Marcarini, Julia Anhoque Cavalcanti [1 ]
Grippa, Wesley Rocha [2 ]
Neto, Luiz Claudio Barreto Silva [1 ]
Podesta, Olivia Perim Galva [3 ]
Bolsoni-Lopes, Andressa [1 ]
Nunes, Karolini Zuqui [1 ,2 ]
Lopes-Junior, Luis Carlos [1 ,2 ]
机构
[1] Fed Univ Espirito Santo UFES, Grad Program Nutr & Hlth, Vitoria, ES, Brazil
[2] Fed Univ Espirito Santo UFES, Grad Program Publ Hlth, Vitoria, ES, Brazil
[3] Univ Multivix, Vitoria, ES, Brazil
关键词
Nutritional status; Breast neoplasms; Chemotherapy; Risk factors; Oncology; QUALITY-OF-LIFE; BODY-FAT; RISK; IMPACT;
D O I
10.1016/j.nut.2024.112411
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objectives: The aim of this study was to evaluate and compare the nutritional status of women with stage I to III breast cancer in the first and third cycles of outpatient chemotherapy and to identify factors associated with it. Methods: The prospective longitudinal study was conducted at a Reference Hospital for Cancer Care in Brazil and included women aged >18 y diagnosed with stage I to III breast cancer receiving outpatient chemotherapy. Assessments were performed during the 1st and 3rd cycles of chemotherapy, including anthropometric measurements, sociodemographic data, clinical information, and quality of life. Nutritional risk was assessed using the NRS-2002. Results: Overweight was predominant in both chemotherapy cycles. Approximately 6.67% and 10% of patients were at nutritional risk in the 1st and 3rd chemotherapy cycles, respectively. Anxiety/depression was prevalent in the 1st chemotherapy cycle and was significantly associated with nutritional risk (P = 0.002). The variables age in cycle 3 and pain/discomfort in cycle 1 (P = 0.049 and P = 0.043, respectively) showed a significant association with nutritional risk. Conclusions: This study highlights the complex interaction between nutritional status, neuropsychological symptoms, and sociodemographic characteristics in breast cancer patients during chemotherapy, and underscores the need for personalized interventions to improve oncological care. (c) 2024 Elsevier Inc. All rights reserved.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] ASSESSMENT OF NUTRITIONAL STATUS OF PATIENTS RECEIVING CHEMOTHERAPY
    Bincy, R.
    Chacko, Beena
    NITTE UNIVERSITY JOURNAL OF HEALTH SCIENCE, 2014, 4 (03): : 33 - 37
  • [22] Prospective Analysis of Food Consumption and Nutritional Status and the Impact on the Dietary Inflammatory Index in Women with Breast Cancer during Chemotherapy
    Dias Custodio, Isis Danyelle
    Franco, Fernanda de Paula
    Marinho, Eduarda da Costa
    Silva Pereira, Taisa Sabrina
    Miranda Lima, Mariana Tavares
    Bisi Molina, Maria del Carmen
    Shivappa, Nitin
    Hebert, James R.
    Paiva, Carlos Eduardo
    de Paiva Maia, Yara Cristina
    NUTRIENTS, 2019, 11 (11)
  • [23] Quality of Life in Women With Breast Cancer Receiving Chemotherapy and the Moderating Role of Cortisol
    Pereira, Ines
    Pereira, Marta
    Leite, Angela
    Graca Pereira, M.
    CANCER NURSING, 2022, 45 (06) : E856 - E864
  • [24] Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis
    Morgan, Eileen
    O'Neill, Colette
    Shah, Richa
    Langselius, Oliver
    Su, Yaqi
    Frick, Clara
    Fink, Hanna
    Bardot, Aude
    Walsh, Paul M.
    Woods, Ryan R.
    Gonsalves, Lou
    Nygard, Jan F.
    Negoita, Serban
    Ramirez-Pena, Esmeralda
    Gelmon, Karen
    Antone, Nicoleta
    Mutebi, Miriam
    Siesling, Sabine
    Cardoso, Fatima
    Gralow, Julie
    Soerjomataram, Isabelle
    Arnold, Melina
    BREAST CANCER RESEARCH, 2024, 26 (01)
  • [25] Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality
    Montserrat Vera-Llonch
    Derek Weycker
    Andrew Glass
    Sue Gao
    Rohit Borker
    Angie Qin
    Gerry Oster
    BMC Cancer, 11
  • [26] Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality
    Vera-Llonch, Montserrat
    Weycker, Derek
    Glass, Andrew
    Gao, Sue
    Borker, Rohit
    Qin, Angie
    Oster, Gerry
    BMC CANCER, 2011, 11
  • [27] Waist Circumference as a Tool for Identifying Visceral Fat in Women with Non-Metastatic Breast Cancer
    Mamede, Vanusa Felicio de Souza
    Bernabe, Rayne de Almeida Marques
    da Silva, Larissa Leopoldino
    Santos, Thalita Goncalves
    Fontana, Luana Gomes
    Machado, Janine Martins
    Albergaria, Ben-Hur
    Marques-Rocha, Jose Luiz
    Guandalini, Valdete Regina
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2024, 76 (04): : 316 - 324
  • [28] Non-metastatic breast cancer specific-survival of patients after treatment with adjuvant chemotherapy
    Duarte Cintra, Jane Rocha
    Guerra, Maximiliano Ribeiro
    Bustamante-Teixeira, Maria Teresa
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2008, 54 (04): : 339 - 346
  • [29] High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancer
    Viens, P
    Gravis, G
    Genre, D
    Bertucci, F
    Cowen, D
    Camerlo, J
    Cappiello, MA
    Conte, M
    Finaud, M
    Chabannon, C
    Houvenaeghel, G
    Maraninchi, D
    BONE MARROW TRANSPLANTATION, 1997, 20 (03) : 199 - 203
  • [30] Potential risk and benefit of the combination of trastuzumab to chemotherapy and radiation therapy in non-metastatic breast cancer
    Belkacemi, Y.
    Laharie-Mineur, H.
    Gligorov, J.
    Azria, D.
    CANCER RADIOTHERAPIE, 2007, 11 (05): : 266 - 275